15353-j-veluchamy

General discussion and Future Prospects Adapted in part from the publication “The rise of allogeneic Natural Killer cells as a platform for cancer immunotherapy: Recent innovations and future developments” Veluchamy JP, Kok N, van der Vliet HJ, Verheul HMW, de Gruijl TD, Spanholtz J. Frontiers in Immunology, 2017 Chapter 6